These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Human-induced pluripotent stem cells-derived retinal pigmented epithelium, a new horizon for cells-based therapies for age-related macular degeneration. Dehghan S; Mirshahi R; Shoae-Hassani A; Naseripour M Stem Cell Res Ther; 2022 May; 13(1):217. PubMed ID: 35619143 [TBL] [Abstract][Full Text] [Related]
5. Restoration of visual function in advanced disease after transplantation of purified human pluripotent stem cell-derived cone photoreceptors. Ribeiro J; Procyk CA; West EL; O'Hara-Wright M; Martins MF; Khorasani MM; Hare A; Basche M; Fernando M; Goh D; Jumbo N; Rizzi M; Powell K; Tariq M; Michaelides M; Bainbridge JWB; Smith AJ; Pearson RA; Gonzalez-Cordero A; Ali RR Cell Rep; 2021 Apr; 35(3):109022. PubMed ID: 33882303 [TBL] [Abstract][Full Text] [Related]
6. Induced pluripotent stem cell therapies for geographic atrophy of age-related macular degeneration. Du H; Lim SL; Grob S; Zhang K Semin Ophthalmol; 2011 May; 26(3):216-24. PubMed ID: 21609235 [TBL] [Abstract][Full Text] [Related]